Wall Street faces mounting pressure amid rising interest rates, with the US 10-year Treasury yield hitting a 14-month high, causing stocks to tumble. Moderna shares plunged 20% after the company lowered its 2025 sales forecast, while Eli Lilly also saw a decline following its announcement to acquire Scorpion Therapeutics' experimental cancer therapy. Retailers' post-holiday results left Wall Street unimpressed, and higher interest rates have driven investors away from gold, causing the yellow metal to drop more than 1%. Meanwhile, oil prices have surged to a four-month high as traders anticipate expanded sanctions and iron ore prices have risen on renewed hopes of Chinese stimulus. Looking ahead, Aussie shares are expected to rise in anticipation of upcoming consumer confidence surveys.

The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.

See omnystudio.com/listener for privacy information.